Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Daiichi Sankyo
Citi
Cantor Fitzgerald
Fuji
Chinese Patent Office
McKesson
US Army
Accenture

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 013625

« Back to Dashboard

NDA 013625 describes NORINYL 1+50 21-DAY, which is a drug marketed by Actavis Labs Ut Inc and is included in one NDA. Additional details are available on the NORINYL 1+50 21-DAY profile page.

The generic ingredient in NORINYL 1+50 21-DAY is mestranol; norethindrone. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mestranol; norethindrone profile page.
Summary for 013625
Tradename:NORINYL 1+50 21-DAY
Applicant:Actavis Labs Ut Inc
Ingredient:mestranol; norethindrone
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.05MG;1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-20Strength0.1MG;2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Argus Health
Fuji
Cerilliant
US Department of Justice
Mallinckrodt
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot